Building Bridges: A Cross-Border Dialogue on Innovation in TechMed illumicell AI & Japan

​DETAILED ACCESS INSTRUCTIONS: https://www.sakuradeeptechshibuya.com/wp/wp-content/themes/sakuradeeptechshibuya_wp/assets/pdf/access_en.pdf

​

​Building Bridges: A Cross-Border Dialogue on Innovation in TechMed illumicell AI & Japan

​
Join us for an energizing panel discussion exploring how Swiss/US-based illumicell AI is working with Japanese investors and advisors to redefine the future of diagnostics. 

​Co-founders Michel Bielecki (CEO) and Jeyla Sadikova (CSO/COO) will share lessons learned from Harvard’s i-lab, insights on AI-driven fertility solutions and firsthand experiences bridging the US-Switzerland-Japan corridor.

​Discussion Highlights

• ​illumicell AI’s Fertility Diagnostics: Real-time analytics powered by artificial intelligence

• ​Harvard i-lab Experience: From academic innovation to clinical impact

• ​Cross-Border Collaboration: Successes, challenges and strategies in working with Japanese investors and advisors
  

​Featured Speakers

• ​Michel Bielecki, MD, MPH – Co-founder & CEO, illumicell AI

• ​Jeyla Sadikova – Co-founder & CSO/COO, illumicell AI

• ​Rob Claar – CEO of Heika Bio; supporting international medtech companies in establishing a presence in Japan

• ​Takumi Ishigami – Venture Capitalist, Bonds Investment Group; specialist in transformative investments

• ​Michael Mroczek – President, Swiss-Japanese Chamber of Commerce;